公司资料
Personalis 股价、新闻与催化剂
- 股票代码:
- PSNL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
13.89 USD (-1.07%)
收盘价
最后更新: 2026年8月17日
1.17B USD
市值
股价为何变动
As of Aug 17, 2026, PSNL closed down 1.07% at $13.89. No new same-company headline was identified in the current news window.
公司概览
Precision-Oncology Genomics
Personalis develops genomic tests for cancer detection, monitoring and therapy development. Its platform uses highly sensitive sequencing and tumor-informed analysis to identify minimal residual disease.
NeXT Personal
NeXT Personal is a personalized circulating-tumor-DNA test designed to detect and track cancer recurrence from blood. Clinical use includes surveillance in lung and breast cancer. Personalis serves physicians through reimbursed clinical testing and pharmaceutical companies through translational research, clinical-trial and biomarker services.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。